ZEB2 PROMOTES THE PROGRESSION OF MASLD BY INDUCING NEUTROPHIL EXTRACELLULAR TRAPS FORMATION (AASLD 2026) - Oct 6, 2026 - Abstract #1325; Pres time: Nov 5, 2026; 12:00 PM - 01:00 PM; Location: Convention Center: Poster Hall, Hall DE; "Hepatocyte ZEB2 drives MASLD progression by inducing NETs formation, and Sitravatinib represents a promising therapeutic agent targeting this pathogenic axis."
Hepatology • Inflammation • Liver Failure • Metabolic Disorders • Metabolic Dysfunction-Associated Steatohepatitis • Metabolic Dysfunction-Associated Steatotic Liver Disease • ACACA • CD36 • FASN • IL1B • IL6 • SCARB1 • TNFA • ZEB2
|
|
Guangqi Zhu1; Qianwen Zhao1; Jie Li1
|